Title
Category
Credits
Event date
Cost
  • Behavioral health
  • 1.00 AMA - Physicians
  • 1.00 ANCC - Nurses
  • 1.00 APA - Psychologists
  • 1.00 Attendance - General Attendance
  • 1.00 CCMC - General - Case Managers
  • 1.00 ASWB - Social Workers
$0.00
This activity will discuss the role of the caregiver, identify barriers to caregiving, establish strategies to support the caregiver and determine available support resources to assist in maintaining the caregiver’s well-being.
  • Behavioral health
  • Older adults
  • 1.00 AMA - Physicians
  • 1.00 ANCC - Nurses
  • 1.00 APA - Psychologists
  • 1.00 Attendance - General Attendance
  • 1.00 CCMC - General - Case Managers
  • 1.00 ASWB - Social Workers
$0.00
This activity will provide an overview of the role of resilience and PIL, examine characteristics associated with resilience and PIL and describe intervention strategies to promote resilience and successful aging in older adults.
  • Disease management
  • Older adults
  • 1.00 ACPE - Pharmacists
  • 1.00 ACPE - Pharmacy Technicians
  • 1.00 AMA - Physicians
  • 1.00 ANCC - Nurses
  • 1.00 APA - Psychologists
  • 1.00 Attendance - General Attendance
  • 1.00 CCMC - General - Case Managers
  • 1.00 ASWB - Social Workers
$0.00
This activity will discuss challenges surrounding hearing health care for individuals with hearing loss, including older adults, and highlight effective techniques, tools and resources for these individuals.
  • Disease management
  • 0.25 ACPE - Pharmacists
  • 0.25 ACPE - Pharmacy Technicians
  • 0.25 AMA - Physicians
  • 0.25 ANCC - Nurses
  • 0.25 APA - Psychologists
  • 0.25 Attendance - General Attendance
$0.00
This patient‑led interview offers a compelling perspective on the real‑world impact of gene therapy for sickle cell disease, highlighting both dramatic physical improvements and the psychological and social adjustments that can follow transformative treatment. Through the patient’s lived experience, learners gain insight into how gene therapy may redefine identity, daily functioning, and long‑term expectations for health. The interview emphasizes the importance of patient‑centered communication, listening to patient expertise, and supporting ongoing mental and emotional adaptation as part of comprehensive, team‑based care.
  • Disease management
  • 0.25 ACPE - Pharmacists
  • 0.25 ACPE - Pharmacy Technicians
  • 0.25 AMA - Physicians
  • 0.25 ANCC - Nurses
  • 0.25 APA - Psychologists
  • 0.25 Attendance - General Attendance
$0.00
This expert interview explores the rapidly evolving role of gene therapy through a practical, clinician‑focused lens. Rather than emphasizing future speculation, the discussion centers on what health care professionals need to know now—how gene-based therapies are entering clinical practice, current understanding of safety and efficacy and the role of clinicians across care settings. By addressing common knowledge gaps between specialists and primary care clinicians and using relatable comparisons to established therapies, the interview highlights the importance of patient education, interdisciplinary communication and timely referral as gene‑based treatments continue to expand.
  • Disease management
  • 0.25 ACPE - Pharmacists
  • 0.25 ACPE - Pharmacy Technicians
  • 0.25 AMA - Physicians
  • 0.25 ANCC - Nurses
  • 0.25 APA - Psychologists
  • 0.25 Attendance - General Attendance
$0.00
This expert interview equips clinicians with practical strategies to identify and manage metabolic‑associated fatty liver disease in everyday practice. Emphasizing early detection in an often asymptomatic population, the discussion focuses on using cardiometabolic risk factors and simple, noninvasive tools such as fibrosis 4 (FIB‑4) to stratify risk and guide next steps. By reinforcing a stepwise, team‑based approach to evaluation, referral and evidence‑based management, the interview helps learners translate emerging advances into timely, actionable care for patients at risk.
  • Disease management
  • Older adults
  • 0.50 AMA - Physicians
  • 0.50 ANCC - Nurses
  • 0.50 Attendance - General Attendance
$0.00
This activity will identify the basic elements of several of the most common syndromes, offer insight into how geriatric syndromes can impact a resident’s daily life and provide a better appreciation of how an individual’s organ systems are interconnected to help mitigate risk and enable development of a better care plan for optimal outcomes.
  • Disease management
  • Older adults
  • 1.00 AMA - Physicians
  • 1.00 ANCC - Nurses
  • 1.00 Attendance - General Attendance
  • 1.00 ASWB - Social Workers
$0.00
Activity descriptionThis on-demand webcast will explore the scope and impact of urinary tract infections (UTIs) in long-term care (LTC) settings, including prevalence, costs and clinical challenges. Participants will learn to differentiate UTIs from asymptomatic bacteriuria, apply evidence-based diagnostic criteria and implement strategies for prevention and treatment. Hydration practices, catheter maintenance and risk reduction to improve resident outcomes and reduce unnecessary antibiotic use will also be discussed.
  • Disease management
  • Older adults
  • 1.00 AMA - Physicians
  • 1.00 ANCC - Nurses
  • 1.00 Attendance - General Attendance
  • 1.00 ASWB - Social Workers
$0.00
Activity descriptionThis activity will introduce the concept of diagnostic stewardship, emphasizing how appropriate test selection impacts patient care. Learners will explore the phases of diagnostic stewardship — pre-analytic, analytic and post-analytic — and learn the importance of pre-test probability in guiding test decisions. Real-world examples will illustrate common pitfalls and best practices in ordering diagnostic tests.
  • Disease management
  • 1.25 ACPE - Pharmacists
  • 1.25 ACPE - Pharmacy Technicians
  • 1.25 AMA - Physicians
  • 1.25 ANCC - Nurses
  • 1.25 APA - Psychologists
  • 1.25 Attendance - General Attendance
  • 1.25 ASWB - Social Workers
$0.00
Gene therapy technologies are revolutionizing treatment for genetic diseases. This session explores the science, clinical applications, and patient perspectives, with a focus on sickle cell disease and emerging technologies like CRISPR.

Pages